News

Home > News & Events > Medial EarlySign CEO to Present at Molecular Medicine Tri-Conference

Medial EarlySign CEO to Present at Molecular Medicine Tri-Conference

Medial EarlySign CEO to Present at Molecular Medicine Tri-Conference
Date

February 11-16, 2018

The Molecular Medicine Tri-Conference brings together thought leaders in the fields of drug discovery, development and diagnostics.  The conference will take place February 11-16, 2018 in San Francisco, CA. Medial EarlySign CEO, Ori Geva, will present on Monday, February 12 on the panel SC20: Best Practices in Personalized and Translational Medicine.

Please contact us to set up a meeting to learn about our work.